Pfizer is also conducting BASIS KIDS, an open-label study investigating the safety and efficacy of HYMPAVZI in children 1 to <18 years of age with severe hemophilia A or moderately severe to ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™ (marstacimab) for adults and ...

So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

For a lot of people, weight loss has nothing to do with willpower; it's got everything to do with biology. You might have heard the buzz around Mounjaro, perhaps your friend has been talking about it, ...

Avery Dennison has introduced a portfolio of RFID-enabled In-Mold Labels (IML) designed to be embedded into plastic items ...

Or, as it’s sometimes called, the ‘magical fifth dose.’ It refers to the leftover liquid left over in the injection pen after the prescribed four doses it contains.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.

German factory in Kierspe expands injection-moulding facilities to include monomaterial lip gloss bottles in PET and PCR ...

News Health NHS Mounjaro weight loss injection eligibility and who cannot take it GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health ...

Wegovy is a prescription injection used for weight loss and reduction of cardiovascular risks. Learn about its dose escalation, form, strengths, and more.